1814
H. Ito et al.
LETTER
2-Bromo-3-phenyl-1-trimethylsiloxy-1-propene (1c):
Ratio major/minor = 89:11 (determined by 1H NMR). Bp
~112 °C/1.5 mmHg. IR (neat): 3029, 2958, 2900, 1731,
1659, 1603, 1495, 1454, 1419, 1333, 1254, 1210, 1172, 868,
849, 748, 698 cm–1. 1H NMR (300 MHz, CDCl3): d (major)
= 7.3–7.2 (m, 5 H), 6.59 (t, J = 0.9 Hz, 1 H), 3.64 (s, 2 H),
0.3–0.2 (m, 9 H); d (minor) = 7.3–7.2 (m, 5 H), 6.64 (t,
J = 0.9 Hz, 1 H), 3.80 (s, 2 H), 0.3–0.2 (m, 9 H). 13C NMR
(75 Hz, CDCl3): d = 138.31, 137.19, 128.62, 128.36, 126.63,
107.44, 41.49, –0.34. MS (EI): m/z (%) = 284 (100), 226
(100).
2-Bromo-2-phenyl-1-(trimethylsiloxy)ethene (1d): Ratio
major/minor = 90:10 (determined by 1H NMR). Bp ~78 °C/
1 mmHg. IR (neat): 3060, 3031, 2958, 1727, 1636, 1491,
1443, 1255, 1167, 935, 758, 694 cm–1. 1H NMR (300 MHz,
CDCl3): d (major) = 7.5–7.2 (m, 4 H), 6.96 (s, 1 H), 0.30 (s,
9 H); d (minor) = 6.50, 7.5–7.2 (m, 4 H), 6.90 (s, 1 H), 0.24
(s, 9 H). 13C NMR (75 MHz, CDCl3): d = 138.50, 129.25,
129.04, 128.32, 127.62, 127.37, –0.27. MS (EI): m/z
(%) = 270 (100), 272 (100).
(EI): m/z (%) = 312(100), 314(100). Minor isomer: IR(neat):
2955, 2929, 2858, 1617, 1259, 1228, 1136, 827 cm–1. 1H
NMR (300 MHz, CDCl3): d = 7.8–7.7 (m, 2 H), 7.4–7.1 (m,
3 H), 6.91 (s, 1 H), 0.91 (s, 9 H), 0.19 (s, 6 H). 13C NMR (75
MHz, CDCl3): d = 140.24, 135.50, 128.99, 127.74, 127.31,
106.93, 25.44, 18.07, –5.30. MS (EI): m/z (%) = 312 (100),
314 (100)
(13) General procedure for the synthesis of 2,2-[60]fullereno-
alkanals. The KF/18-crown-6 method: KF (5.8 mg, 0.10
mmol) and an 18-crown-6 solution in toluene (0.10 M, 0.20
mL, 0.020 mmol) were added to a solution of [60]fullerene
(72 mg, 0.10 mmol) and 2-BrESE (0.10 mmol) in toluene
(72 mL). After the mixture was stirred at r.t. for 72 h, the
solvent was evaporated to dryness. The residue was purified
by preparative thin layer chromatography (SiO2, CS2) to
afford the corresponding 2,2-[60]fullerenoalkanal as a dark-
brown solid.
The TBAF method: A TBAF solution (1 M in THF, 0.30
mL, 0.30 mmol) was added to a solution of [60]fullerene (72
mg, 0.10 mmol) and 2-BrESE (0.10 mmol) in toluene (72
mL). After the mixture was stirred at r.t. for 3 h, the solvent
was evaporated to dryness. The residue was purified by
column chromatography [SiO2; hexane–toluene, 9:1 to 2:1
(v/v)] to afford the corresponding 2,2-[60]fullerenoalkanal
as a dark-brown solid.
2-Bromo-1-trimethylsiloxyethene (1e): Bp ~74 °C/52
mmHg. IR (neat): 3106, 3010, 2960, 2901, 1636, 1329,
1255, 1241, 1166, 1094, 878, 849, 757, 708, 655, 605 cm–1.
1H NMR (300 MHz, CDCl3): d = 6.73 (d, J = 3.9 Hz, 1 H),
5.24 (d, J = 3.9 Hz, 1 H), 0.24 (s, 9 H). 13C NMR (75 MHz,
CDCl3): d = 141.41, 87.37, –0.43. MS (EI): m/z (%) = 194
(100), 196 (100)
2,2-[60]Fullerenobutanal (2a): See ref. 5.
2,2-[60]Fullerenododecanal (2b): IR (KBr): 2921, 2849,
1719, 1461, 1428, 1186, 578, 555, 526 cm–1. 1H NMR (300
MHz, CDCl3): d = 10.57 (s, 1 H), 2.79 (t, J = 8.1 Hz, 2 H),
2.02–1.85 (m, 2 H), 1.66–1.18 (m, 14 H), 0.89 (t, J = 6.6 Hz,
3 H). 13C NMR [125 MHz, CDCl3/CS2, 1:1 (v/v)]: d =
194.24, 146.84, 145.79, 145.26, 145.25, 145.23, 145.16,
145.13, 144.97, 144.70, 144.64, 144.62, 144.60, 144.40,
143.76, 143.69, 143.19, 143.08, 143.01, 142.94, 142.92,
142.91, 142.05, 141.98, 141.97, 141.57, 141.10, 141.04,
137.96, 137.83, 75.17, 50.23, 31.99, 30.05, 29.71, 29.69,
29.55, 29.46, 27.70, 25.87, 22.84, 14.23. MS (MALDI-
TOF): m/z [M]·+ calcd for C72H22O: 902.17; found: 902.11.
2,2-[60]Fullereno-3-phenylpropanal (2c): IR (KBr): 2922,
2850, 1718, 1494, 1427, 1260, 1186, 1073, 1030, 732, 706,
576, 555, 526 cm–1. 1H NMR (300 MHz, CDCl3): d = 10.55
(s, 1 H), 7.58 (d, J = 7.4 Hz, 2 H), 7.38 (dd, J = 7.4, 7.4 Hz,
2 H), 7.30 (d, J = 7.4 Hz, 1 H), 4.23 (s, 2 H). 13C NMR [125
MHz, CDCl3/CS2, 1:1 (v/v)]: d = 193.83, 146.85, 145.61,
145.38, 145.35, 145.28, 145.27, 144.98, 144.82, 144.81,
144.80, 144.78, 144.76, 144.58, 143.88, 143.78, 143.20,
143.18, 143.06, 143.01, 142.17, 142.10, 142.07, 141.62,
141.24, 138.15, 138.12, 136.77, 129.40, 128.95, 127.25,
74.98, 50.15, 31.56; three peaks are overlapped. MS
(MALDI-TOF): m/z [M]·+ calcd for C69H8O: 852.06; found:
851.80.
(11) The enol tert-butyldimethylsilyl ethers 4c¢ and 4d¢ were
synthesized according to a method in the literature,16 and
was purified by silica gel column chromatography.
1-tert-Butyldimethylsilyloxy-3-phenylpropene (4c¢):
IR(neat): 3029, 2955, 2929, 2858, 1655, 1255, 1115, 838
cm–1. 1H NMR (300 MHz, CDCl3): d = 7.4–7.1 (m, 5 H),
6.30 (dt, J = 5.7, 1.5 Hz, 1 H), 4.67 (dt, J = 5.7, 7.2 Hz, 1 H),
3.45 (dd, J = 1.5, 7.2 Hz, 2 H), 0.94 (s, 9 H), 0.15 (s, 6 H).
13C NMR (75 MHz, CDCl3): d = 141.97, 139.10, 128.32,
128.25, 125.58, 109.08, 29.92, 25.63, 18.26, –5.33. MS (EI):
m/z = 248.
1-tert-Butyldimethylsilyloxy-2-phenylethene (4d¢): Ratio
major/minor = 52:48 (determined by 1H NMR). IR (neat):
3030, 2955, 2930, 2885, 2858, 1645, 1471, 889, 838, 783,
692 cm–1. 1H NMR (300 MHz, CDCl3): d (major) = 7.3–7.1
(m, 5 H), 7.00 (d, J = 12.3 Hz, 1 H), 6.03 (d, J = 12.3 Hz,
1 H), 0.96 (s, 9 H), 0.21 (s, 6 H); d (minor) = 7.7–7.6 (m,
2 H), 7.3–7.1 (m, 3 H), 6.42 (d, J = 6.6 Hz, 1 H), 5.30 (d,
J = 6.6 Hz, 1 H), 0.98 (s, 9 H), 0.22 (s, 6 H). 13C NMR (75
MHz, CDCl3): d = 142.23, 140.51, 136.47, 136.19, 128.49,
128.18, 128.07, 125.73, 125.63, 125.12, 112.82, 108.84,
25.68, 25.62, 18.32, 18.21, –5.18, –5.38. MS (EI): m/z = 234
(12) The 2-bromoenol tert-butyldimethylsilyl ethers 1c¢ and 1d¢
were synthesized in a similar manner to that used for the
preparation of the 2-boromoenol trimethylsilyl ethers. The
crude products were purified by column chromatography
[SiO2; hexane–CH2Cl2, 10:0 to 8:2 (v/v)].
2,2-[60]Fullereno-2-phenylethanal (2d): See ref. 7.
2,2-[60]Fullerenoethanal (2e): See ref. 7.
(14) [60]Fullerene derivatives having two or more alkanal
moieties were obtained as by-products.
2-Bromo-1-tert-butyldimethylsilyloxy-3-phenylpropene
(1c¢): IR(neat): 3029, 2954, 2929, 2858, 1659, 1254, 1211,
1171, 838 cm–1. 1H NMR (300 MHz, CDCl3): d = 7.4–7.2
(m, 5 H), 6.61 (s, 1 H), 3.64 (s, 2 H), 0.96 (s, 1 H), 0.19 (s,
1 H). 13C NMR (75 MHz, CDCl3): d = 138.38, 137.72,
128.63, 128.34, 126.61, 106.92, 441.42, 25.51, 18.27, –5.17.
MS (EI): m/z (%) = 326 (100), 328 (100).
2-Bromo-1-tert-butyldimethylsilyloxy-2-phenylethene
(1d¢): Ratio major/minor = 65:35 (determined by 1H NMR).
Major isomer: IR (neat): 2954, 2929, 2858, 1635, 1261,
1168, 828 cm–1. 1H NMR (300 MHz, CDCl3): d = 7.5–7.4
(m, 2 H), 7.4–7.2 (m, 3 H), 6.98 (s, 1 H), 0.99 (s, 1 H), 0.24
(s, 1 H). 13C NMR (75 MHz, CDCl3): d = 138.91, 137.11,
128.31, 127.53, 127.32, 106.74, 25.50, 18.26, –5.11. MS
(15) Br2 (0.40 M in CH2Cl2, 1.25 mL, 0.50 mmol) and Et3N (1.5
M in CH2Cl2, 0.50 mL, 0.75 mmol) were successively added
dropwise to a solution of 1-trimethylsilyloxy-1-butene (4a;
72 mg, 0.50 mmol) in CH2Cl2 (7.5 mL) at –78 °C, and the
mixture was stirred at r.t. for 3 h. A solution of [60]fullerene
(0.10 mM in toluene, 72 mL), KF (29 mg, 0.50 mmol), and
18-crown-6 (26 mg, 0.10 mmol) were successively added to
the mixture. After the mixture was stirred at r.t. for 42 h, the
solvent was evaporated to dryness. The residue was purified
by preparative thin layer chromatography (SiO2, CS2) to
afford 2,2-[60]fullerenobutanal 1a (36 mg, 0.46 mmol, 46%
yield) as a dark-brown solid
(16) Jung, M. E.; Nishimura, N. Org. Lett. 2001, 3, 2113.
Synlett 2010, No. 12, 1811–1814 © Thieme Stuttgart · New York